Seeking patients with autoimmune blistering skin conditions

The Lubeck Study: A prospective study on serum antibodies against target antigens of bullous autoimmune diseases and genetic susceptibility

This study aims to see how effective a new blood test (using a diagnostic test called EUROIMMUN biochip) is in diagnosing and monitoring autoimmune blistering skin diseases, in comparison to the standard blood test.

Participants will be asked to donate an additional sample of blood which will be used for research into genetic susceptibility to autoimmune blistering skin disease. Only one visit is required and this usually will occur at the time of your visit at The Royal Melbourne Hospital.

Anticipated date that enrolment will close: February 2020

Who can take part

  • Diagnosis or suspected immunolullous disease

What is involved for you

  • Blood test a single visit
check
Non-Drug
Phase 1
Phase 2
Phase 3
Phase 4

For more information

Quote reference number
2017.210
Annette Phemister
03 9342 4531
Brent Doolan
03 9342 4531